Hourly refreshSun, Nov 1, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

SaaS

4,174 press releases in English indexed under saas.

Clear all filters
Keywords, dates and language
Sources
up to 10
Newswires (50)
Company newsrooms (91)
Companies
Releases linked to any of up to 10 companies
AllFinanceCryptoAISaaSHealthcareReal estateEnergyRetailAutomotiveGamingMediaEducation
+ 33 more topics
DownloadExcelTXT
SaaS · Healthcare

Health practices can now send eScripts directly from the patient record in Zanda

e-Prescribing Software for Australian Practices New integration lets authorised prescribers create, send and manage electronic prescriptions from Zanda, with patient details synced automatically. This has been a great product. It has made prescribing so much easier for myself and more reliable for clients” — Dr Yolandie Goodyear BALLARAT, VICTORIA, AUSTRALIA, October 26, 2026 / EINPresswire.com / -- Zanda, the global

Oct 26 · 07:15EIN Presswire
Finance · Crypto

OpenWorld Confirms Dual Listing on Figure OPEN on Track for Q4 2026 Following Stockholder Approval of Blockchain Common Stock

LAKE MARY, Fla., October 26, 2026 - OpenWorld, Inc. (NASDAQ: OPNW) (“OpenWorld” or the “Company”), a blockchain innovation company advancing real-world asset tokenization, today confirmed that its planned dual listing on Figure’s On-chain Public Equity Network (“Figure OPEN”) remains on track to go live in the fourth quarter of 2026. OpenWorld expects to be among the first Nasdaq-listed companies to bring its public equity on-chain, giving institutional and retail investors a new way to hold and trade shares of a U.S. exchange-listed company without leaving the regulatory boundaries of the existing securities framework. The update follows stockholder approval on October 16, 2026 of the Company’s Amended and Restated Articles of Incorporation (“Restated Articles”), which authorizes a new class of Blockchain Common Stock. As disclosed in the Company’s Current Report on Form 8-K filed on October 16, 2026. This is the corporate mechanism required to bring OpenWorld’s equity onto Figure OPEN No New Shares – One Company, Two Ways to Trade The Figure OPEN listing does not involve the issuance of any new shares and will not raise capital. OpenWorld’s Blockchain Common Stock will serve as a blockchain-native version of the Company’s existing Nasdaq-listed shares, giving stockholders the choice of holding and trading OPNW shares on Nasdaq or on Figure OPEN. Blockchain Common Stock is designed to settle in real time, rather than on the conventional T+1 cycle, and to trade around the clock. The Company’s total number of outstanding shares will not increase. “Bringing OPNW on-chain has been part of our vision since day one, and we remain on track to execute this vision with Figure OPEN later this quarter,” said Matthew Shaw, Chief Executive Officer and Chairman of OpenWorld. “Bringing our shares on-chain through Figure OPEN provides our existing stockholders with greater choice, without any dilution, as markets increasingly move 24/7 through blockchain rails. When we go live on Figure OPEN, our shareholders can trade on Nasdaq as they always have or hold the same ownership as a blockchain-native share with faster settlement and extended trading access. We believe this is where public markets are heading, and we intend to be at the front of it.” Delivering on the Dual-Listing Plan As announced on October 1, 2026, OpenWorld is pursuing a dual listing on Figure OPEN, building on its previously announced agreement with Figure Technology Solutions, Inc. (NASDAQ: FIGR) to offer a digitally native share class. With stockholder approval secured, OpenWorld expects the Figure OPEN listing to be live later this quarter. The Figure OPEN listing is designed to complement, not replace, the Company’s Nasdaq listing. OpenWorld remains subject to the same SEC reporting requirements, corporate governance standards and investor protections. Compliant Transfer Agent to Simplify the Dual Structure To make moving between the two formats simple for stockholders, OpenWorld has appointed Vinyl Equity, Inc., an SEC-registered transfer agent equipped to maintain records for both traditional and blockchain-based shares. The transfer agent will support stockholders who wish to hold their shares in either form. OpenWorld will provide information on how stockholders can access the blockchain-based shares. Charter Amendments Approved On September 30, 2026, OpenWorld’s Board of Directors approved the Restated Articles and submitted them to stockholders. On October 16, 2026, stockholders holding approximately 57.57% of the Company’s issued and outstanding common stock, a majority of its outstanding voting power, approved the Restated Articles by written consent under Section 78.320 of the Nevada Revised Statutes. The amendments provide for: - The authorization of 500,000,000 shares of Blockchain Common Stock, par value $0.001 per share, as a “blank check” class issuable in one or more series. - An express election permitting the Company to make distributions that would otherwise be prohibited by NRS 78.288(2)(b). Upon effectiveness, OpenWorld’s authorized capital stock will consist of 675,000,000 shares of Common Stock, 500,000,000 shares of Blockchain Common Stock and 75,000,000 shares of Preferred Stock, each with a par value of $0.001 per share. Authorized shares represent the maximum the Company may issue and do not change the number of shares outstanding. The Restated Articles will become effective upon filing with the Nevada Secretary of State following the expiration of the applicable notice period under Rule 14c-2 under the Securities Exchange Act of 1934, as amended, following the mailing of OpenWorld’s definitive Information Statement on Schedule 14C to its stockholders, which is expected to begin on October 26, 2026. About OpenWorld OpenWorld, Inc. (NASDAQ: OPNW) is a digital assets and blockchain technology company. Through its OpenWorld Enterprise platform, the Company provides financial structuring and blockchain infrastructure for the issuance and distribution of tokenized real-world assets to institutional and retail investors. To learn more, visit openworld.dev. Forward-Looking Statements This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the timing of filing and effectiveness of the Company’s Restated Articles, the timing of the Company’s definitive Information Statement on Schedule 14C being mailed to the Company’s stockholder, the timing and expected benefits of the Company’s listing on Figure OPEN, the issuance and characteristics of Blockchain Common Stock, and the services of the Company’s transfer agent. Words such as “believe,” “expects,” “intends,” “planned,” “will,” and similar expressions identify forward-looking statements. These statements are subject to risks and uncertainties, including regulatory approvals, market conditions and technology readiness, that could cause actual results to differ materially. Investors should not place undue reliance on forward-looking statements, which speak only as of the date of this release. OpenWorld undertakes no obligation to update them except as required by law. Additional risks are described in the Company’s filings with the SEC. Contacts Investors: OpenWorldIR@allianceadvisors.com   Media: Aayushi@allianceadvisors.com  NMS Equity Transfer Agent: Vinyl Equity, Inc., 1-888-80-VINYL (84695) Blockchain Equity Transfer Agent: Figure Equity Solutions, Inc., support@figuremarkets.com Source: Form 8-K filed with the SEC. Prior announcements: October 1 Nasdaq listing; Figure agreement.

Oct 26 · 05:30ACN Newswire
SaaS · Biotech & pharma

From Animal Source to Full-Chain Controllability: Cloud-Clone Primary Cells for Customized Research Needs

In-house SPF animal facility enables traceable, tailor-made primary cell solutions for life-science and drug-discovery projects HUSTON, TX, UNITED STATES, October 26, 2026 / EINPresswire.com / -- Primary cells serve as the gold-standard in-vitro model for life-science studies and new-drug development, faithfully recapitulating native cellular morphology, gene-expression profiles and physiological functions of donor a

Oct 26 · 05:17EIN Presswire
SaaS · Logistics

Barmeter Technologies Issues Statement on Sai Kumar Pola’s Warehouse Robotics Research and API Traffic Management Patent

Company highlights simulation-based findings on autonomous fleet reliability and a later patent application’s citation of Pola’s earlier invention Company highlights simulation-based findings on autonomous fleet reliability and a later patent application’s citation of Pola’s earlier invention

Oct 26 · 05:11GlobeNewswire
SaaS · Healthcare

Allenby Cosmetic Dermatology Partners with Aviva Aesthetics, Bringing the Platform to Florida

Internationally recognized cosmetic dermatologist Dr. Janet Allenby joins Aviva's growing national network of founder-led aesthetic practices CHICAGO, Oct. 25, 2026 -- Aviva Aesthetics, the only entrepreneur-owned national platform built for medical aesthetics practice...

Oct 26 · 05:02PRWeb
Finance · AI

American Hospital Dubai and HEI Global Health Announce Strategic Partnership to Collaboratively Build an Advanced AI-Powered Revenue Cycle Innovation

American Hospital Dubai Named Inaugural Alpha Partner for RevOptix™, HEI Global Health's Next-Generation Revenue Cycle and Patient Accounting Intelligence Platform DUBAI, United Arab Emirates, October 26, 2026--American Hospital Dubai ("AHD"), one of the Middle East's premier private healthcare provide

Oct 26 · 05:00Business Wire
SaaS · Biotech & pharma

ACS Nano Study Presents Multifunctional Nanotherapy Modulating the Joint-Brain Axis for Rheumatoid Arthritis

Cloud-Clone antibodies enable key target biomarker detection to validate dual peripheral-central therapeutic effects HUSTON, TX, UNITED STATES, October 26, 2026 / EINPresswire.com / -- Rheumatoid arthritis (RA) is widely recognized as a chronic autoimmune disorder primarily damaging joints. More than half of RA patients also suffer from neuropsychiatric comorbidities including anxiety, depression and cognitive impair

Oct 26 · 04:58EIN Presswire
SaaS · Biotech & pharma

Nature Communications Study Reveals Angiotensin-II-Driven Mechanism for Exacerbated Intracerebral Hemorrhage

Cloud-Clone ELISA kits and monoclonal antibody deliver critical tools for unraveling receptor-independent coagulation dysregulation HUSTON, TX, UNITED STATES, October 26, 2026 / EINPresswire.com / -- Hypertensive intracerebral hemorrhage (ICH) carries high mortality and disability risks. Researchers have long observed a puzzling “thrombosis-hemorrhage paradox”: activated renin-angiotensin-aldosterone-system (RAAS) an

Oct 26 · 04:58EIN Presswire
SaaS · Insurance

Wolters Kluwer selected by IFFCO Tokio General Insurance to support Ind AS 117 and Ind AS 116 compliance with CCH® Tagetik

CCH Tagetik enables Ind AS 117 and Ind AS 116 reporting with integrated disclosure capabilities on a unified platform MUMBAI, India, October 26, 2026--Wolters Kluwer , a global leader in professional information, software solutions and services, today announced that IFFCO Tokio General Insurance Compa

Oct 26 · 04:30Business Wire
SaaS

IGEN SME Platform: Global Leadership Opportunity for CXOs

Bengaluru, Karnataka, India, 26th October 2026, FinanceWire … Read More The post IGEN SME Platform: Global Leadership Opportunity for CXOs appeared first on FinanceWire - Financial Press Release Distribution, Finance PR.

Oct 26 · 04:27FinanceWire
SaaS

L&T Technology Services and Nokia Forge Engineering Collaboration

Highlights: Collaboration to support Nokia engineering and R&D activities in India Work to include product engineering, new product development, system integration and ongoing support BENGALURU, India, October 26, 2026--L&T Technology Services (BSE: 540115, NSE: LTTS), announced it has established a f

Oct 26 · 03:45Business Wire
SaaS

Study Uncovers Hypertension‑Osteoarthritis Link via AVP‑AVPR1A Axis

Cloud-Clone Copeptin ELISA kits deliver critical quantitative evidence supporting the landmark neuroendocrine crosstalk discovery HUSTON, TX, UNITED STATES, October 26, 2026 / EINPresswire.com / -- Osteoarthritis (OA) ranks among the most prevalent chronic joint disorders worldwide, long interpreted mainly as an outcome of mechanical joint wear. Growing epidemiological observations have identified hypertension as an

Oct 26 · 03:08EIN Presswire